Siemens brings Dotmatics into industrial stack

Siemens buying Dotmatics turns lab software into one module inside a much bigger factory software stack. Dotmatics sells the systems scientists use to capture experiment data, manage samples, search past results, and analyze biology workflows, while Siemens already sells software and automation used to design products and run production. That creates a credible path to connect early research data with later process development, quality, and manufacturing systems in one vendor relationship.1 2 3 4 5

• Dotmatics is not a narrow point tool. Its portfolio spans ELN, data management, sequence analysis, flow cytometry, visualization, and instrument data ingestion, which overlaps directly with Benchling’s pitch of being the core system of record for modern biotech R&D.2 6 7
• The strategic change is distribution as much as product. After the July 1, 2025 close, Dotmatics moved into Siemens Digital Industries Software, giving it access to a parent that already sells automation and lifecycle software to large industrial customers across design and production environments.1 4 5
• Benchling is still competing from a stronger cloud native R&D collaboration position, with about $210M ARR and 1,200 customers as of May 2024. But the Siemens tie up means some buyers can now evaluate Dotmatics as part of a broader digital thread from lab work to plant operations.3 8 1

The market is heading toward platform buying, where pharma and biotech companies try to reduce handoffs between discovery, development, and manufacturing. That favors vendors that can connect scientist workflows with production systems, so Benchling will need to keep proving that a modern R&D system of record can expand outward faster than industrial incumbents can move inward.1 3 4 5